These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12526018)

  • 21. Agarose isoelectric focusing of unconcentrated CSF and radioimmunofixation for detection of oligoclonal bands in patients with multiple sclerosis and other neurological diseases.
    Kostulas VK; Link H
    J Neurol Sci; 1982 Apr; 54(1):117-27. PubMed ID: 7042918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhastSystem and immunofixation.
    Hackler R; Schäfer JR; Motzny S; Brand S; Kleine TO; Kaffarnik H; Steinmetz A
    J Lipid Res; 1994 Jan; 35(1):153-8. PubMed ID: 8138717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.
    Eto M; Watanabe K; Ishii K
    Clin Chim Acta; 1985 Jun; 149(1):21-8. PubMed ID: 4028432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.
    Moriwaki Y; Yamamoto T; Takahashi S; Tsutsumi Z; Higashino K
    Ann Rheum Dis; 1995 May; 54(5):351-4. PubMed ID: 7794039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations.
    Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
    Clin Chem; 1999 Apr; 45(4):497-504. PubMed ID: 10102909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis.
    Gelman BB; Rifai N; Christenson RH; Silverman LM
    Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
    Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
    Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agarose isoelectric focusing, antiserum immunofixation and silver staining for detection of oligoclonal bands in unconcentrated cerebrospinal fluid.
    Radosavljević B
    Acta Neurol Scand; 1986 Feb; 73(2):208-12. PubMed ID: 2422867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrepancies between apolipoprotein E phenotyping and genotyping in the elderly.
    Dupuy AM; Badiou S; Ritchie K; Mas E; Descomps B; Cristol JP; Touchon J
    Clin Chem Lab Med; 2001 May; 39(5):405-13. PubMed ID: 11434390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting.
    McDowell IF; Wisdom GB; Trimble ER
    Clin Chem; 1989 Oct; 35(10):2070-3. PubMed ID: 2791274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
    Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
    Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism.
    Kamboh MI; Ferrell RE; Kottke B
    J Lipid Res; 1988 Nov; 29(11):1535-43. PubMed ID: 3241128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a).
    Ritter MM; Gewitsch J; Richter WO; Geiss HC; Wildner MW; Schwandt P
    Atherosclerosis; 1997 Jun; 131(2):243-8. PubMed ID: 9199278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of apolipoprotein E phenotypes from stored or postmortem serum samples.
    Lehtimäki T
    Clin Chim Acta; 1991 Dec; 203(2-3):177-82. PubMed ID: 1777978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of the apolipoprotein E polymorphism and genetic variants: current methods for apo E phenotyping.
    Steinmetz A
    Ann Biol Clin (Paris); 1991; 49(1):1-8. PubMed ID: 2048769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved phenotyping of apolipoprotein E: application to population frequency distribution.
    Hill JS; Pritchard PH
    Clin Chem; 1990 Nov; 36(11):1871-4. PubMed ID: 2242561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination.
    Rifai N; Christenson RH; Gelman BB; Silverman LM
    Clin Chem; 1987 Jul; 33(7):1155-7. PubMed ID: 3594843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia.
    Kim JH; Lee EJ; Kwon OH
    Clin Biochem; 1997 Feb; 30(1):47-52. PubMed ID: 9056109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.